SIL204 treatment may help immune system attack KRAS-driven tumors, research finds - exclusive
--------------------------------------------------------------------
Source: The Jerusalem Post
Published: 2026-08-05 22:04 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Science, Health
--------------------------------------------------------------------
Snippet:
SIL204, a treatment being developed by Israeli company Silexion Therapeutics Corp., may help the immune system identify and attack KRAS-driven cancers, according to preclinical findings released on Wednesday.
--------------------------------------------------------------------